Stock JBCHEPHARM J. B. CHEMICALS & PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company J. B. Chemicals & Pharmaceuticals Limited

Equities

JBCHEPHARM

INE572A01036

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:50 2024-04-26 am EDT 		5-day change 1st Jan Change
1,864 INR +0.48% Intraday chart for J. B. Chemicals & Pharmaceuticals Limited +4.81% +14.75%
Apr. 08 J. B. Chemicals & Pharmaceuticals Limited Appoints Akshay Tanna as A Non-Executive, Non-Independent Director CI
Mar. 22 J. B. Chemicals & Pharmaceuticals Limited Receives Order from Assessment Unit, Income Tax Department CI

Business Summary

J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its therapeutic categories include gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives and pharmacovigilance. The Company's lozenges products include center-filled, soft-centered lozenges; center-filled, powder lozenges; herbal lozenges, and medicated lozenges. The Company offers a complete range of contrast media products including X-ray, MRI, and ultrasound in India as well as internationally. The Company produces a wide range of dosage forms, such as tablets, capsules, liquids, IV infusions, ampoules, vials, ointments, cold rubs, lozenges and sips. Its brands include Rantac OD, RD, Ranraft, Metrogyl ER, Metrogyl O, Nicardia XL, Sporlac EVA and Sporlac G, among others.

Number of employees: 5,095

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceuticals Products
98.9 %
23,841 98.3 % 31,137 98.9 % +30.60%
Miscellaneous Income
0.4 %
115 0.5 % 134 0.4 % +16.68%
Export Incentives
0.3 %
85 0.3 % 100 0.3 % +17.54%
Exchange Rate Difference
0.1 %
98 0.4 % 44 0.1 % -55.25%
Scrap
0.1 %
35 0.1 % 29 0.1 % -16.96%
Product Development
0.1 %
37 0.2 % 28 0.1 % -23.87%
Government Grant
0.0 %
17 0.1 % 16 0.0 % -9.63%
Insurance Claims
0.0 %
14 0.1 % 5 0.0 % -62.78%

Sales per region

INR in Million2022Weight2023Weight Delta
India
52.1 %
11,882 49.0 % 16,396 52.1 % +38.00%
International
47.9 %
12,361 51.0 % 15,096 47.9 % +22.13%

Managers

Managers TitleAgeSince
Nikhil Ashok Kumar Chopra CEO
 Chief Executive Officer 51 20-10-04
Bharat Dhanani COO
 Chief Operating Officer - -
Sujay Rajhans CTO
 Chief Tech/Sci/R&D Officer - -
Sridhar Bharadwaj ADM
 Chief Administrative Officer - -
Kunal Khanna COO
 Chief Operating Officer - -
Suresh Bhise CTO
 Chief Tech/Sci/R&D Officer - 14-05-31
Jason D'Souza IRC
 Investor Relations Contact - -
Anurag Agarwal LAW
 General Counsel - 22-04-30
Dilip Singh Rathore PRN
 Corporate Officer/Principal - -
Bal Krishen Dhar PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Padmini Khare Kaicker BRD
 Director/Board Member 59 20-08-30
Akshay Tanna BRD
 Director/Board Member 40 Nov. 06
Gaurav Trehan BRD
 Director/Board Member 48 21-02-09
Sumit Bose BRD
 Director/Board Member 69 20-08-30
Nikhil Ashok Kumar Chopra CEO
 Chief Executive Officer 51 20-10-04
Prashant Kumar BRD
 Director/Board Member - 20-07-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 155,194,800 71,103,939 ( 45.82 %) 0 45.82 %

Shareholders

NameEquities%Valuation
Kohlberg Kravis Roberts & Co. LP
53.78 %
83,464,664 53.78 % 1 651 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt)
3.148 %
4,885,823 3.148 % 97 M ₹
Axis Asset Management Co. Ltd.
2.688 %
4,171,420 2.688 % 82 M ₹
Norges Bank Investment Management
1.593 %
2,472,312 1.593 % 49 M ₹
Invesco Asset Management (India) Pvt Ltd.
1.207 %
1,873,374 1.207 % 37 M ₹
Canara Robeco Asset Management Co. Ltd.
1.152 %
1,788,403 1.152 % 35 M ₹
Franklin Templeton Asset Management (India) Pvt Ltd.
0.9335 %
1,448,723 0.9335 % 29 M ₹
Edelweiss Asset Management Ltd.
0.8432 %
1,308,622 0.8432 % 26 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
0.8429 %
1,308,182 0.8429 % 26 M ₹
HSBC Asset Management (India) Pvt Ltd.
0.8299 %
1,287,942 0.8299 % 25 M ₹

Company contact information

J.B. Chemicals & Pharmaceuticals Ltd.

Cnergy IT Park Appa Saheb Marathe Marg, Prabhadevi

400025, Mumbai

+91 22 2439 5200

http://www.jbpharma.com
address J. B. Chemicals & Pharmaceuticals Limited(JBCHEPHARM)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for J. B. Chemicals & Pharmaceuticals Limited

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1,864 INR
Average target price
1,882 INR
Spread / Average Target
+0.95%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
J. B. CHEMICALS & PHARMACEUTICALS LIMITED Stock J. B. Chemicals & Pharmaceuticals Limited
+14.75% 3.47B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. JBCHEPHARM Stock
  4. Company J. B. Chemicals & Pharmaceuticals Limited